VieScope in Patients With an Expected Difficult Airway

June 29, 2022 updated by: Universitätsklinikum Hamburg-Eppendorf

Tracheal Intubation With VieScope Versus Videolaryngoscopy in Patients for Elective Surgery With an Expected Difficult Airway - a Prospective Randomized Trial (VieScOP-II)

Patients requiring endotracheal intubation for elective surgery with an expected difficult airway are randomized to be intubated either by a) VieScope or b) videolaryngoscopy.

Study Overview

Status

Completed

Conditions

Detailed Description

Tracheal intubation is required for different surgical procedures for mechanical ventilation and to prevent aspiration of secretions. In patients with an expected difficult airway, tracheal intubation is often performed by videolaryngoscopy (VL). However, this technique has limitations and may fail due to insufficient visualization of the larynx. A new device has been introduced that consists of an illuminated straight plastic tube for laryngoscopy (VSC, Vie Scope, Adroit Surgical, Oklahoma City, OK, USA) that enables for indirect intubation over a stylet.

So far, the VSC has shown promising results in manikin studies for intubation in normal and difficult airways. We aim to test the VSC in patients compared to videolaryngoscopy in a prospective randomized non-inferiority trial.

Patients will be assessed for eligibility in the Anesthesiology Pre-assessment Clinic of the University Medical Center Hamburg-Eppendorf prior to elective surgery. All patients receive a structured preoperative airway assessment.

Patients are randomized 1:1 to either intervention or control group. Patients randomized to the intervention group will be intubated with the VSC. Patients randomized to the control group are intubated with a MacIntosh type videolaryngoscope (CMAC, Storz, Germany).

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • HH
      • Hamburg, HH, Germany, 20246
        • Universitätsklinikum Hamburg-Eppendorf

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients requiring general anesthesia with transoral tracheal intubation for elective surgery
  • Age ≥ 18
  • Preoperative airway assessment reveals an expected difficult airway (rated by the responsible anesthetist in the Pre-assessment Clinic based on the existing in-house algorithm)

Exclusion Criteria:

  • Pregnant or breastfeeding woman
  • Confirmed indications for awake fiberoptic intubation especially due to enoral, pharyngeal tumors, abscesses or other processes
  • Planned endotracheal intubation without deep anesthesia or neuromuscular blocking agents (e.g. awake videolaryngoscopy)
  • Required transnasal tracheal intubation (e.g. for surgical reasons)
  • Requirement of special endotracheal tubes such as laser or RAE tubes for surgical reasons
  • Patients at risk for pulmonary aspiration who qualify for rapid sequence induction
  • Loose teeth
  • Denial of consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: VieScope
intubation with the VieScope laryngoscope
intubation with VieScope laryngoscope
ACTIVE_COMPARATOR: Videolaryngoscopy
intubation with videolaryngoscope
intubation with videolaryngoscope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of Glottis Opening (POGO) scale
Time Frame: 15 min
intubating conditions according to the percentage of glottis opening scale (POGO), range 0-100%, higher values better
15 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
overall success rate
Time Frame: 15 min
percentage of successful intubations with the allocated procedure
15 min
intubation difficulty
Time Frame: 15 min
subjective rating on a visual analogue scale (0-100, higher values indicate more difficult intubation) of the difficulty of airway management and questionnaire
15 min
number of attempts
Time Frame: 15 min
total number of attempts until airway established
15 min
aspiration
Time Frame: 15 min
percentage of patients that vomit and aspirate during intubation
15 min
esophageal intubation
Time Frame: 15 min
percentage of accidental esophageal intubation attempts
15 min
hypoxia
Time Frame: 15 min
percentage of patients with a desaturation below a pulsoximetric saturation of 80%
15 min
hypotension
Time Frame: 15 min
percentage of patients with a systolic blood pressure below 70 mmHg
15 min
first attempt success rate
Time Frame: 15 min
percentage of successful intubations with one attempt
15 min
time to intubation
Time Frame: 15 min
time until tracheal airway access is established
15 min
Cormack-Lehane
Time Frame: 15 min
intubating conditions according to Cormack-Lehane
15 min
time to successful intubation with one attempt
Time Frame: 15 min
time until tracheal airway access is established in patients that are intubated at first attempt
15 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 11, 2021

Primary Completion (ACTUAL)

June 26, 2022

Study Completion (ACTUAL)

June 26, 2022

Study Registration Dates

First Submitted

September 5, 2021

First Submitted That Met QC Criteria

September 5, 2021

First Posted (ACTUAL)

September 14, 2021

Study Record Updates

Last Update Posted (ACTUAL)

July 1, 2022

Last Update Submitted That Met QC Criteria

June 29, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • VieScOP-II

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Management

Clinical Trials on VieScope

Subscribe